Medications for the treatment of HIV - Updated July, 2008
It should be understood that only a small percentage of people suffer debilitating side effects, and in most cases the side effects can be controlled if they know in advance what to expect if they should they occur. For information on where and how these medications work see T.A.S.K. lesson 2. For tips on managing side effects and adherence see T.A.S.K. lesson 3.

Entry and Fusion Inhibitors.

Expanded Access means that the medication is in the final stages of approval by the FDA and is available to those failing on current medications. Your doctor or case manager can contact the company and enroll you it the Expanded Access Program. Expanded Access Programs stop taking new patients when medications are approved; however, they may be available through Patient Assistance Programs, once approved, for those who cannot afford the medication, do not have insurance and cannot qualify for other assistance programs. Click on "Finances" for more information on these programs.

Medication
Name
Usual Adult Dose
Possible Side Effects
Manufacturer & Patient Assistance Program information

Fuzeon enfuvirtide T-20

One tablet (150mg Epivir & 300mg Retrovir) twice a day(bid); with or without food
See Epivir & Retrovir

Roche

Roche Patient Assistance Foundation

1-877-75ROCHE (877-757-6243)

Selzentry

Maraviroc

150mg or 300mg tablets taken twice a day(bid) - your doctor will determin the best dose for you. For more information go to:

https://www.pfizerpro.com/patient_

education/selzentry_medication_guide.pdf

Few side effects noted - Possible liver toxicity and allergic rash reaction - should be used with caution in patients co-infected with Hepatitis - Note: this medication works for patients who's virus is CCR5 trophic (uses this receptor to enter the t-cell) - additional testing required

Pfizer

https://www.pfizer helpfulanswers.com/ pages/misc/Default.aspx

1-866-776-3700